What we do
Create the pathway. Accelerate the approval.
We transform innovative discoveries into differentiated therapeutics that reach prescribers and patients sooner.
- 01Proof of concept
- 02Clinical development
- 03Regulatory filing
- 04Review
- 05Approved label
- 06Commercialization
Development trajectory
From proof of concept to an approved label.
Clinical development
Regulatory filing
Review
Approved label
Commercialization
We help pharmaceutical, biotechnology and medical product companies pursue timely, comprehensive first-cycle regulatory approvals. Programs are optimized through clinical development, regulatory filing and review, approved labeling and placement in the marketplace.
Pathway creation
No precedent is where our work begins.
01
Our mix of prescribers, former sponsors and reviewers from regions around the world—together with international success guiding and rescuing development programs—positions us to accelerate the path to approval.
02
Partner with us to explore new ways to advance development, create a new regulatory pathway or establish an accelerated pathway.
Lifecycle01 02 03
Concept to commercialization, treated as one system.
Scientific translation
Distill nonclinical and clinical research into evidence a regulator can understand and act on.
Health authority strategy
Prepare decisions and interactions with the benefit-risk picture in full view.
Program optimization
Align development, submission, review, labeling and commercial readiness.
Create the pathway
Move from possibility to approval.
Share the regulatory decision, development challenge or pathway that needs experienced judgment.
Schedule a consultation